JP2024544415A - 動物における呼吸器疾患の治療のための注射用医薬組成物 - Google Patents
動物における呼吸器疾患の治療のための注射用医薬組成物 Download PDFInfo
- Publication number
- JP2024544415A JP2024544415A JP2024537407A JP2024537407A JP2024544415A JP 2024544415 A JP2024544415 A JP 2024544415A JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024544415 A JP2024544415 A JP 2024544415A
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- injectable pharmaceutical
- compound
- formula
- animals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217704 | 2021-12-24 | ||
| EP21217704.2 | 2021-12-24 | ||
| PCT/EP2022/087700 WO2023118557A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544415A true JP2024544415A (ja) | 2024-11-29 |
| JP2024544415A5 JP2024544415A5 (cg-RX-API-DMAC7.html) | 2026-01-05 |
Family
ID=79601675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537407A Pending JP2024544415A (ja) | 2021-12-24 | 2022-12-23 | 動物における呼吸器疾患の治療のための注射用医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057790A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4452226A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024544415A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118632684A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128074A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022420882A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3242451A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007862A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023118557A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021335500A1 (en) | 2020-09-04 | 2023-05-04 | Elanco Us Inc. | Palatable formulations |
| AR134777A1 (es) | 2023-12-21 | 2026-04-01 | Intervet Int Bv | Formas cristalinas de sales de (s)-n-(3-amino-1-(hidroxiamino)-3-metil-1-oxobutan-2-il)-4-((4-(((2-metoxietil)amino)metil)fenil)etinil)benzamida |
| CN122422289A (zh) | 2023-12-21 | 2026-07-17 | 英特维特国际股份有限公司 | (s)-n-(3-氨基-1-(羟基氨基)-3-甲基-1-氧代丁-2-基)-4-((4-(((2-甲氧基乙基)氨基)甲基)苯基)乙炔基)苯甲酰胺盐的结晶形式的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| JP7082445B2 (ja) | 2016-12-23 | 2022-06-08 | インターベット インターナショナル ベー. フェー. | ウシ又はブタの呼吸器疾患を治療するための化合物 |
-
2022
- 2022-12-22 AR ARP220103558A patent/AR128074A1/es unknown
- 2022-12-23 MX MX2024007862A patent/MX2024007862A/es unknown
- 2022-12-23 CA CA3242451A patent/CA3242451A1/en active Pending
- 2022-12-23 US US18/721,947 patent/US20250057790A1/en active Pending
- 2022-12-23 AU AU2022420882A patent/AU2022420882A1/en active Pending
- 2022-12-23 CN CN202280085114.3A patent/CN118632684A/zh active Pending
- 2022-12-23 JP JP2024537407A patent/JP2024544415A/ja active Pending
- 2022-12-23 EP EP22844124.2A patent/EP4452226A1/en active Pending
- 2022-12-23 WO PCT/EP2022/087700 patent/WO2023118557A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA3242451A1 (en) | 2023-06-29 |
| WO2023118557A1 (en) | 2023-06-29 |
| US20250057790A1 (en) | 2025-02-20 |
| AU2022420882A1 (en) | 2024-06-20 |
| MX2024007862A (es) | 2024-07-09 |
| EP4452226A1 (en) | 2024-10-30 |
| AR128074A1 (es) | 2024-03-20 |
| CN118632684A (zh) | 2024-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250057790A1 (en) | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals | |
| JP4772324B2 (ja) | ウシおよびブタにおける感染を処置するための組成物および方法 | |
| AU2004247053B2 (en) | Compositions for treating infection in cattle and swine | |
| Stipkovits et al. | The efficacy of valnemulin (Econor®) in the control of disease caused by experimental infection of calves with Mycoplasma bovis | |
| JP2006528705A5 (cg-RX-API-DMAC7.html) | ||
| MXPA06012303A (es) | Uso de formulaciones de meloxicam en medicina veterinaria. | |
| JP6276469B2 (ja) | ブタ用飼料中のナラシンの抗ウイルス作用 | |
| Dorrestein et al. | Clinical pharmacology and pharmacokinetics of flumequine after intravenous, intramuscular and oral administration in pigeons (Columba livid) | |
| BR0016262B1 (pt) | Processo para produção de uma formulação para injeção não-aquosa de valnemulina | |
| US20020068065A1 (en) | Pharmaceutical composition having specific water activity | |
| CN113476431A (zh) | 一种环三酮衍生物在制备动物用药中的应用 | |
| Nagaraja | Liver abscesses in beef cattle: potential for dairy monitoring? | |
| KR20250106485A (ko) | 동물의 피부 질환을 치료하기 위한 조성물 | |
| Aboubakr et al. | Bioavailability, pharmacokinetics and tissue residues of cephradine (Atocef Forte®) in healthy and colisepticemic broiler chickens | |
| CN119158025A (zh) | 一种用于治疗动物支原体感染的药物制剂及其应用 | |
| McMullan | Effects of subclinical parasitism on beef production | |
| KR20210145045A (ko) | 세균의 복합 감염에 의한 동물의 호흡기 질환 치료용 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251219 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251219 |